OPHTHALMISCHE FORMULIERUNG

Patent europeic · EP3761960 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3761960
Numer da la dumonda
EP19708337
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
08-03-2019
Publitgà
13-01-2021
Concedì
22-11-2023
La protecziun finescha il pli tard
07-03-2039
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 9/08 (2006.01)
A61K 47/42 (2017.01)
A61K 31/381 (2006.01)
Prioritad
EP 18160981 09.03.2018
Dumonda PCT
PCT/EP2019/055818 08.03.2019
Publicaziun PCT
WO2019/170848 12.09.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 02-10-2024

    Midada

    Published in Swissreg on 02.10.2024

  4. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  5. 21-03-2024

    Adressa midada

    Owner
    Kiora Pharmaceuticals GmbH, Reisnerstraße 34/1, 1030 Wien, Germany → Kiora Pharmaceuticals GmbH, Herrengasse 5/3/6, 1010 Wien, Austria

    Published in Swissreg on 21.03.2024

  6. 22-11-2023

    Concedì

    Published in Swissreg on 22.11.2023

Partidas

Possessur

Kiora Pharmaceuticals GmbH

Herrengasse 5/3/6, 1010 Wien, AT

Inventur

SPERL, Stefan

1050 Vienna, AT

OBERMAYR, Franz

1010 Vienna, AT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.